Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
CNY 34.06
(-4.0%)
CNY 34.06
(-4.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 893.66 Million CNY | 1409.68% |
| 2022 | -68.23 Million CNY | 33.94% |
| 2021 | -103.28 Million CNY | -1347.78% |
| 2020 | -7.13 Million CNY | -167.37% |
| 2019 | 10.59 Million CNY | -72.05% |
| 2018 | 37.89 Million CNY | -37.79% |
| 2017 | 60.91 Million CNY | -8.95% |
| 2016 | 66.9 Million CNY | 2.36% |
| 2015 | 65.36 Million CNY | 50.95% |
| 2014 | 43.3 Million CNY | 38.96% |
| 2013 | 31.16 Million CNY | -24.4% |
| 2012 | 41.21 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.5 Billion CNY | 17.55% |
| 2024 Q2 | 1.28 Billion CNY | 5.36% |
| 2024 Q1 | 1.21 Billion CNY | 36.3% |
| 2023 Q2 | 72.49 Million CNY | 177.75% |
| 2023 FY | 893.66 Million CNY | 1409.68% |
| 2023 Q4 | 893.66 Million CNY | 98.4% |
| 2023 Q3 | 450.42 Million CNY | 521.29% |
| 2023 Q1 | -93.25 Million CNY | -36.66% |
| 2022 Q3 | -318.33 Million CNY | -72.21% |
| 2022 Q2 | -184.84 Million CNY | -58.97% |
| 2022 Q1 | -116.27 Million CNY | -12.57% |
| 2022 FY | -68.23 Million CNY | 33.94% |
| 2022 Q4 | -68.23 Million CNY | 78.56% |
| 2021 FY | -103.28 Million CNY | -1347.78% |
| 2021 Q3 | -148.91 Million CNY | -13.44% |
| 2021 Q2 | -131.27 Million CNY | -2704.82% |
| 2021 Q1 | -4.68 Million CNY | 34.4% |
| 2021 Q4 | -103.28 Million CNY | 30.64% |
| 2020 Q2 | 3.81 Million CNY | 0.0% |
| 2020 Q3 | -8.09 Million CNY | -312.19% |
| 2020 Q1 | 3.81 Million CNY | -63.96% |
| 2020 Q4 | -7.13 Million CNY | 11.91% |
| 2020 FY | -7.13 Million CNY | -167.37% |
| 2019 Q4 | 10.59 Million CNY | 0.0% |
| 2019 FY | 10.59 Million CNY | -72.05% |
| 2018 FY | 37.89 Million CNY | -37.79% |
| 2017 Q2 | 72.28 Million CNY | 0.0% |
| 2017 Q1 | 72.28 Million CNY | 8.04% |
| 2017 FY | 60.91 Million CNY | -8.95% |
| 2016 Q2 | 102.81 Million CNY | 0.0% |
| 2016 FY | 66.9 Million CNY | 2.36% |
| 2016 Q3 | 66.9 Million CNY | -34.93% |
| 2016 Q4 | 66.9 Million CNY | 0.0% |
| 2016 Q1 | 102.81 Million CNY | 57.31% |
| 2015 Q2 | 16.96 Million CNY | 0.0% |
| 2015 Q1 | 16.96 Million CNY | -60.81% |
| 2015 FY | 65.36 Million CNY | 50.95% |
| 2015 Q4 | 65.36 Million CNY | 0.0% |
| 2015 Q3 | 65.36 Million CNY | 285.2% |
| 2014 Q4 | 43.3 Million CNY | 0.0% |
| 2014 FY | 43.3 Million CNY | 38.96% |
| 2014 Q2 | 30.74 Million CNY | 6.62% |
| 2014 Q1 | 28.83 Million CNY | -7.45% |
| 2014 Q3 | 43.3 Million CNY | 40.82% |
| 2013 Q4 | 31.16 Million CNY | 0.0% |
| 2013 FY | 31.16 Million CNY | -24.4% |
| 2013 Q1 | 27.78 Million CNY | 0.0% |
| 2013 Q3 | 31.16 Million CNY | 0.0% |
| 2012 FY | 41.21 Million CNY | 0.0% |